Senate panel hears of conflict in drugmaker-doctor relations

06/27/2007 | Washington Post, The · NYTimes.com

Nearly two-thirds of the cost of continuing education courses in medicine is sponsored by drugmakers, according to testimony at a Senate committee hearing. A pharmaceutical industry executive said funding of continuing medical education is an important way to give physicians the latest medical and scientific research news.

View Full Article in:

Washington Post, The · NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA